Task: Answer the multiple choice question.
Question: Which compound exhibits a 11.314% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: COc1ccc(CNCC(O)(c2ccc(Cl)cc2)c2ccc(Cl)cc2)cc1
b: CC1=NOC(=O)/C1=C/c1ccc(N(C)C)cc1
c: CN1C(=O)C(CC(=O)NCCc2ccccc2)N(NC(=O)c2cccc(F)c2)C1=S
Answer: c. CN1C(=O)C(CC(=O)NCCc2ccccc2)N(NC(=O)c2cccc(F)c2)C1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1C(=O)C(CC(=O)NCCc2ccccc2)N(NC(=O)c2cccc(F)c2)C1=S
CN1C(=O)C(CC(=O)NCCc2ccccc2)N(NC(=O)c2cccc(F)c2)C1=S
5-fluoro-N-[3-methyl-4-oxo-5-[2-oxo-2-(2-phenylethylamino)ethyl]-2-sulfanylideneimidazolidin-1-yl]benzamide